In our study, we found that BAF60a overexpression led to a remarkable increase in H3K9-me2 (repression) levels accompanied by a reduction of H3K4-me3 (activation) levels on the Cps1 promoter in DF-treated mouse PHs (Fig. S5A). The gene discussed is SMARCD1; the disease is Pallister-Hall syndrome.